Medico Remedies Ltd. (IN:MEDICO)
:MEDICO
MEDICO Stock Chart & Stats
₹50.16
₹4.58(8.10%)
At close: 4:00 PM EST
₹50.16
₹4.58(8.10%)
Day’s Range― - ―
52-Week Range₹31.00 - ₹62.00
Previous CloseN/A
Volume2.72M
Average Volume (3M)12.74K
Market Cap
₹3.24B
Enterprise Value₹3.37B
Total Cash (Recent Filing)₹17.64M
Total Debt (Recent Filing)₹125.27M
Price to Earnings (P/E)36.5
Beta0.17
Next Earnings
May 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.35
Shares Outstanding82,984,000
10 Day Avg. Volume20,955
30 Day Avg. Volume12,740
Financial Highlights & Ratios
PEG Ratio1.99
Price to Book (P/B)7.06
Price to Sales (P/S)2.92
P/FCF Ratio258.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Robust Revenue GrowthMedico Remedies' sustained revenue growth indicates durable demand and successful market penetration in its specialty & generic drug segments. Persistent top-line expansion supports capacity utilization and scale advantages, underpinning longer-term earnings resilience and reinvestment potential over the next 2–6 months.
Improving ProfitabilityImproving net and healthy gross margins suggest effective cost management and pricing power versus peers. Margin expansion enhances free cash generation and the ability to fund growth or deleverage, making profitability gains a structurally positive driver of financial durability and shareholder returns potential.
Prudent Leverage And Equity BaseA solid equity base and favorable debt-to-equity ratio provide financial flexibility and lower refinancing risk. Improving return on equity indicates effective capital use. Together these traits strengthen the firm's capacity to invest, withstand shocks, and access funding on reasonable terms over the medium term.
Bears Say
Capital Expenditure Pressure On FCFElevated capex that depresses free cash flow relative to net income can limit liquidity for dividends, debt reduction, or opportunistic investments. If capex persists, the company's ability to convert profits into discretionary cash will be constrained, reducing financial optionality over coming quarters.
Volatile Operating (EBIT) EfficiencyUnstable EBIT margins indicate earnings sensitivity to cost swings or pricing pressure. Operating efficiency volatility undermines earnings predictability and makes planning for reinvestment or debt servicing harder, raising execution risk for sustaining recent profitability improvements over time.
Moderate Reliance On LiabilitiesA moderate reliance on liabilities means the company is somewhat dependent on external funding. While current leverage is described as favorable, ongoing dependence on liabilities increases exposure to interest rate moves and refinancing cycles, creating a structural financing risk to monitor.
Medico Remedies Ltd. News
MEDICO FAQ
What was Medico Remedies Ltd.’s price range in the past 12 months?
Medico Remedies Ltd. lowest stock price was ₹31.00 and its highest was ₹62.00 in the past 12 months.
What is Medico Remedies Ltd.’s market cap?
Medico Remedies Ltd.’s market cap is ₹3.24B.
When is Medico Remedies Ltd.’s upcoming earnings report date?
Medico Remedies Ltd.’s upcoming earnings report date is May 30, 2026 which is in 50 days.
How were Medico Remedies Ltd.’s earnings last quarter?
Medico Remedies Ltd. released its earnings results on Feb 12, 2026. The company reported ₹0.346 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.346.
Is Medico Remedies Ltd. overvalued?
According to Wall Street analysts Medico Remedies Ltd.’s price is currently Overvalued.
Does Medico Remedies Ltd. pay dividends?
Medico Remedies Ltd. does not currently pay dividends.
What is Medico Remedies Ltd.’s EPS estimate?
Medico Remedies Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medico Remedies Ltd. have?
Medico Remedies Ltd. has 82,984,000 shares outstanding.
What happened to Medico Remedies Ltd.’s price movement after its last earnings report?
Medico Remedies Ltd. reported an EPS of ₹0.346 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.509%.
Which hedge fund is a major shareholder of Medico Remedies Ltd.?
Currently, no hedge funds are holding shares in IN:MEDICO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medico Remedies Ltd.
Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.
Technical Analysis
Albert David Ltd
―
Brooks Laboratories Limited
―
Lyka Labs Limited
―
―
Zim Laboratories Ltd.
―